On 18 July 2017
Jubilant Life Sciences will hold a meeting of the Board of Directors of the Company on 18 July 2017 to inter-alia consider Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2017.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
